SysteMHC v.231201
Home Datasets Download Help About Update

Showing details for project SYSMHC00008



SampleID NumReplicates Organism TissueType CellType MHCAllele
SampleID NumReplicates Organism TissueType CellType MHCAllele
SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject3_rep3 5 Human HLA-A02:01,HLA-A29:02,HLA-B57:01,HLA-B44:03
SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject3_rep4 5 Human HLA-A02:01,HLA-A29:02,HLA-B57:01,HLA-B44:03
SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject3_rep5 5 Human HLA-A02:01,HLA-A29:02,HLA-B57:01,HLA-B44:03
SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject4_rep3 5 Human HLA-A01:01,HLA-A02:01,HLA-B18:01,HLA-B39:24
SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject4_rep4 5 Human HLA-A01:01,HLA-A02:01,HLA-B18:01,HLA-B39:24
SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject4_rep5 5 Human HLA-A01:01,HLA-A02:01,HLA-B18:01,HLA-B39:24
SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject4_rep6 5 Human HLA-A01:01,HLA-A02:01,HLA-B18:01,HLA-B39:24



Detailed view of sample SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject3_rep5



ID SampleID RawFileName Organism Process Tissue Type Cell Type Culture Conditions Disease State Comments MHCClass MHCAllele PubMed ID Peptide Isolation Method Antibody Mass Spectrometer LC System iRT Peptides Acquisition Mode Fragmentation Method Gradient Gradient Length Flow Rate Replicate Number
ID SampleID RawFileName Organism Process Tissue_Type Cell_Type Culture_Conditions Disease_State Comments MHCClass MHCAllele PubMed_ID Peptide Isolation_Method Antibody Mass_Spectrometer LC_System iRT_Peptides Acquisition_Mode Fragmentation_Method Gradient Gradient_Length Flow_Rate Replicate_Number
SYSMHC00008 SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject3_rep5 SYSMHC00008_Subject3_rep5_021213_Fx100mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02:01,HLA-A29:02,HLA-B57:01,HLA-B44:03 26728094 native Mild acid elution Orbitrap Elite LTQ no DDA CID 3-60% 120 1
SYSMHC00008 SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject3_rep5 SYSMHC00008_Subject3_rep5_021213_Fx300mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02:01,HLA-A29:02,HLA-B57:01,HLA-B44:03 26728094 native Mild acid elution Orbitrap Elite LTQ no DDA CID 3-60% 120 2
SYSMHC00008 SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject3_rep5 SYSMHC00008_Subject3_rep5_021213_Fx50mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02:01,HLA-A29:02,HLA-B57:01,HLA-B44:03 26728094 native Mild acid elution Orbitrap Elite LTQ no DDA CID 3-60% 120 3
SYSMHC00008 SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject3_rep5 SYSMHC00008_Subject3_rep5_021213_Fx600mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02:01,HLA-A29:02,HLA-B57:01,HLA-B44:03 26728094 native Mild acid elution Orbitrap Elite LTQ no DDA CID 3-60% 120 4
SYSMHC00008 SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject3_rep5 SYSMHC00008_Subject3_rep5_021213_Fx75mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02:01,HLA-A29:02,HLA-B57:01,HLA-B44:03 26728094 native Mild acid elution Orbitrap Elite LTQ no DDA CID 3-60% 120 5